Breaking News
February 16, 2019 - Conformance of genetic characteristics found to be crucial for longer preservation of kidney graft
February 16, 2019 - Researchers use optogenetic tool to control, visualize receptor signals in neural cells
February 16, 2019 - New reversible antiplatelet therapy could reduce risk of blood clots, prevent cancer metastasis
February 16, 2019 - Testosterone is not the only hormone needed for penis development
February 16, 2019 - FDA Advisory Committee Recommends Approval of Spravato (esketamine) Nasal Spray for Adults with Treatment-Resistant Depression
February 15, 2019 - Heart surgery technology developed at Baptist Health debuts after years of secrecy
February 15, 2019 - Prescription Opioids Double Risk of Triggering Fatal Car Crash
February 15, 2019 - New study helps doctors better understand high blood pressure in pregnant women
February 15, 2019 - Beta wave control in Parkinson’s diseased brain could be a potential therapy
February 15, 2019 - Media representations of love may justify gender-based violence in young people
February 15, 2019 - Yoga May Help With Rheumatoid Arthritis Symptoms, Severity
February 15, 2019 - Obstructive sleep apnea linked to inflammation, organ dysfunction
February 15, 2019 - Master your mind: A challenge from WELL for Life
February 15, 2019 - Why Some Brain Tumors Respond to Immunotherapy
February 15, 2019 - Must-Reads Of The Week From Brianna Labuskes
February 15, 2019 - Researchers uncover novel mechanism and potential new therapeutic target for Alzheimer’s
February 15, 2019 - Genetic variations in a fourth gene associated with higher ALL risk in Hispanic children
February 15, 2019 - Disruptive behavioral problems in kindergarten linked with lower employment earnings in adulthood
February 15, 2019 - New bioengineered device enhances the production of T-cells
February 15, 2019 - HDL proteome behaves like a tiny Velcro ball that is rolling on surfaces
February 15, 2019 - Puerto Rican children more likely to have poor or decreasing use of asthma inhalers
February 15, 2019 - Quality of patient care does not improve after physician-hospital integration
February 15, 2019 - Synopsys release new software for implant design and patient-specific planning
February 15, 2019 - 6 out of 10 hip replacements last 25 years or longer
February 15, 2019 - Health Tip: What You Should Know About Antibiotics
February 15, 2019 - New research challenges medical consensus that adenoids and tonsils significantly shrink during teenage years
February 15, 2019 - Discovery of weakness in a rare cancer could be exploited with drugs
February 15, 2019 - UVA scientists find potential explanation for mysterious cell death in Alzheimer’s, Parkinson’s
February 15, 2019 - New rules requiring female athletes to lower testosterone levels are based on flawed data
February 15, 2019 - Researchers comprehensively sequence the human immune system
February 15, 2019 - Researchers study animal venoms to identify new medicines for treating diseases
February 15, 2019 - Movement of wrist bones revealed by MRI and computer modeling
February 15, 2019 - Philips introduces new premium digital X-ray room to help shorten patient wait times
February 15, 2019 - Women fare worse than men following aortic heart surgery, study finds
February 15, 2019 - High-protein and low-calorie diet helps older adults lose weight safely, shows study
February 15, 2019 - Drug microdosing effects may not measure up to big expectations
February 15, 2019 - Discharged, Dismissed: ERs Often Miss Chance To Set Overdose Survivors On ‘Better Path’
February 15, 2019 - A digitized lab environment to be showcased at smartLAB 2019
February 15, 2019 - Scientists uncover main mechanisms of fluconazole drug resistance
February 15, 2019 - New study seeks to understand how colibactin causes cancer
February 15, 2019 - Photoacoustic imaging accurately measures the temperature of deep tissues
February 15, 2019 - Large study finds no association between phthalate exposure and breast cancer risk
February 15, 2019 - New research explains presence of ‘natural’ magnetism in human cells
February 15, 2019 - Bio-Rad launches new digital PCR system and kit for monitoring treatment response in CML patients
February 15, 2019 - Scientists shed light on damaging cell effects linked to aging
February 15, 2019 - Celiac disease may be caused by stomach bug in childhood
February 15, 2019 - NHS performance figures highlight the true scale of Emergency Department crisis
February 15, 2019 - High intensity exercise may improve health by increasing gut microbiota diversity
February 15, 2019 - Apellis’ APL-2 Receives Orphan Drug Designation from the FDA for the Treatment of Autoimmune Hemolytic Anemia
February 15, 2019 - Couples creating art or playing board games release ‘love hormone’
February 15, 2019 - Glimpsing The Future At Gargantuan Health Tech Showcase
February 15, 2019 - Common herbicide found to increase the risk of lymphoma
February 15, 2019 - Over-abundance of energy to cells could increase cancer risk
February 15, 2019 - Oxford Genetics appoints Jocelyne Bath as new Chief Operating Officer
February 15, 2019 - Castration-resistant metastatic prostate cancer responds to combination of immune checkpoint inhibitors
February 15, 2019 - Large-scale clinical trial begins to study liver transplantation between people with HIV
February 15, 2019 - Cannabis use among adolescents linked with increased risk of depression in adulthood
February 15, 2019 - Fractures, head injuries common in electric scooter accidents, UCLA study finds
February 15, 2019 - Prenatal maternal depression has important consequences for infant temperament, study shows
February 15, 2019 - Stereotactic body radiotherapy effective in treating men with low- or intermediate-risk prostate cancer
February 15, 2019 - Zogenix Submits New Drug Application to U.S. Food & Drug Administration for Fintepla for the Treatment of Dravet Syndrome
February 15, 2019 - Certain birthmarks warrant quick treatment, pediatricians say
February 15, 2019 - New machine learning method predicts if atypical ductal hyperplasia will turn cancerous
February 15, 2019 - Whole-genome sequencing and sharing real-time data could limit spread of foodborne bacteria
February 15, 2019 - FDA warns doctor for illegally marketing unapproved implantable device
February 15, 2019 - New injury documentation tool may provide better evidence for elder abuse cases
February 15, 2019 - Physiological age is a better predictor of survival than chronological age, shows study
February 15, 2019 - New study reveals high success rate for hip and knee replacements
February 15, 2019 - Prenatal exposures to BPA may pose threat to human ovarian function
February 15, 2019 - Suspicious spots on the lungs of children with rhabdomyosarcoma do not behave like metastases
February 15, 2019 - Diet drinks daily could raise stroke risk says study
February 15, 2019 - Many Systematic Reviews Do Not Fully Report Adverse Events
February 15, 2019 - Seven tips to protect your child from burns
February 15, 2019 - Keynote speakers announced for CBD Expo MIDWEST
February 15, 2019 - New DNA methylation GrimAge tool allows you to predict lifespan and healthspan
February 15, 2019 - New AI-driven platform analyze how pathogens infect human cells
February 15, 2019 - Increased activity of EHMT2 gene deficient neurons could cause autism in humans
February 15, 2019 - Recurring UTIs may mask symptoms of bladder or kidney cancer
February 15, 2019 - Researchers conduct extensive comparison of drugs used in treating neuroendocrine tumors
February 15, 2019 - Depression prevention for pregnant women and new mothers – new recommendations
Study gives insights into how better clinical trials can address ‘critically low’ dementia research

Study gives insights into how better clinical trials can address ‘critically low’ dementia research

image_pdfDownload PDFimage_print

New research gives insights into how the design of clinical trials can improve to address the “critically low” research pipeline and improve the chances of finding effective dementia therapies.

Against a backdrop of a number of high-profile clinical trial failures, research by the University of Exeter, presented in posters at the Alzheimer’s Association International Conference (AAIC) 2018, highlights the importance of conducting more targeted trials. It gives insights into how to obtain better evidence that potential treatments may be effective, and how to recruit specific groups of people to trials.

Research presented at the conference highlights that there are currently 142 active clinical trials in Alzheimer’s disease worldwide. Of these, only 42 are on disease-modifying therapies, only 29 of which were in phase 2 or 3 in drugs, small molecules or biological therapies – meaning they have any meaningful chance of translating to disease-modifying treatment for Alzheimer’s disease. The research found this figure to be 40-fold lower than the number of cancer trials at this phase of progression.

Clive Ballard, Professor of Age-Related Diseases at the University of Exeter Medical School, said: “When we drilled down into the number of active clinical trials in dementia we revealed that the number that could make a meaningful difference to treating disease is now critically low. With no new licensed treatments in the last 20 years, addressing this shortfall is an urgent priority. Our research outlines the new approach needed to enable us to do better by the 40 million people worldwide who have dementia, and for an economy which is projected to spend a trillion dollars on treating this disease by the end of 2018.”

The research also revealed the targets that clinical trials are focussing on, highlighting where the scientific community thinks the best hope of treatment currently lies. Of the 29 identified by the team, ten are looking at treatment or approaches to amyloid and four at tau – both proteins that can build up in the brain. Three focus on neurotransmitters while three more are on repositioning other existing drugs. One is a regenerative treatment and one is targeting neuroinflammation.

Further research by the team highlights how future research can be targeted and conducted more efficiently. Conducting trials in groups such as those at high risk of developing dementia means fewer participants are needed to obtain an equal statistical power and reliability of results.

Increasingly, research is focussing on the early stages of dementia and dementia prevention, however the costs involved in recruitment are high, as large numbers are needed because of the varying pathways involved in dementia.

The Exeter-led study looked at data from the participants who were given placebos in three randomized clinical trials, of 939 people. They analyzed biomarkers and risk factors such as genetics, the presence of amyloid plaque in the brain and a family history of Alzheimer’s disease. They found that considering these factors significantly increases the power per patient screened to detect the potential for treatment to effect brain function.

In a study sponsored by the Wellcome Trust and led by King’s College London, working with Exeter, researchers analyzed a library of compounds 1,300 in the Broad Institute connectivity Map, to select which would be the best candidates to take forward to clinical trials for Alzheimer’s disease. They used mouse models to look at which of these compounds changed MRNA expression in cancer cells, making them candidates as disease-modifying treatments in dementia.

Of these, they then 83 to test in cells, and selected the most promising six of those to take forward in mice. They analyzed aspects including whether they protect cells from exposure to amyloid or tau proteins, implicated in dementia, or whether they protect synapse and nerve activity.

The researchers conclude that this approach can increase the potential to screen existing compounds that have potential to be effective treatments for Alzheimer’s disease, and refine those that should be taken forward to clinical trial.

Source:

http://www.exeter.ac.uk/news/featurednews/title_672105_en.html

Tagged with:

About author

Related Articles